Literature DB >> 18079715

Preferential delivery of the Sleeping Beauty transposon system to livers of mice by hydrodynamic injection.

Jason B Bell1, Kelly M Podetz-Pedersen, Elena L Aronovich, Lalitha R Belur, R Scott McIvor, Perry B Hackett.   

Abstract

Nonviral, DNA-mediated gene transfer is an alternative to viral delivery systems for expressing new genes in cells and tissues. The Sleeping Beauty (SB) transposon system combines the advantages of viruses and naked DNA molecules for gene therapy purposes; however, efficacious delivery of DNA molecules to animal tissues can still be problematic. Here we describe the hydrodynamic delivery procedure for the SB transposon system that allows efficient delivery to the liver in the mouse. The procedure involves rapid, high-pressure injection of a DNA solution into the tail vein. The overall procedure takes <1 h although the delivery into one mouse requires only a few seconds. Successful injections result in expression of the transgene in 5-40% of hepatocytes 1 d after injection. Several weeks after injection, transgene expression stabilizes at approximately 1% of the level at 24 h, presumably owing to integration of the transposons into chromosomes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18079715      PMCID: PMC2548418          DOI: 10.1038/nprot.2007.471

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  74 in total

1.  Development of hyperactive sleeping beauty transposon vectors by mutational analysis.

Authors:  Hatem Zayed; Zsuzsanna Izsvák; Oliver Walisko; Zoltán Ivics
Journal:  Mol Ther       Date:  2004-02       Impact factor: 11.454

2.  Combinatorial antiangiogenic gene therapy by nonviral gene transfer using the sleeping beauty transposon causes tumor regression and improves survival in mice bearing intracranial human glioblastoma.

Authors:  John R Ohlfest; Zachary L Demorest; Yasuhiko Motooka; Isabelita Vengco; Seunguk Oh; Eleanor Chen; Frank A Scappaticci; Rachel J Saplis; Stephen C Ekker; Walter C Low; Andrew B Freese; David A Largaespada
Journal:  Mol Ther       Date:  2005-09-16       Impact factor: 11.454

3.  Integration site selection by HIV-based vectors in dividing and growth-arrested IMR-90 lung fibroblasts.

Authors:  Angela Ciuffi; Richard S Mitchell; Christian Hoffmann; Jeremy Leipzig; Paul Shinn; Joseph R Ecker; Frederic D Bushman
Journal:  Mol Ther       Date:  2005-12-01       Impact factor: 11.454

4.  RNA as a source of transposase for Sleeping Beauty-mediated gene insertion and expression in somatic cells and tissues.

Authors:  Andrew Wilber; Joel L Frandsen; Jennifer L Geurts; David A Largaespada; Perry B Hackett; R Scott McIvor
Journal:  Mol Ther       Date:  2005-12-20       Impact factor: 11.454

5.  Integrating DNA vectors for gene therapy.

Authors:  Perry B Hackett
Journal:  Mol Ther       Date:  2007-01       Impact factor: 11.454

6.  Naked plasmid DNA transfer to the porcine liver using rapid injection with large volume.

Authors:  H Yoshino; K Hashizume; E Kobayashi
Journal:  Gene Ther       Date:  2006-07-27       Impact factor: 5.250

7.  Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells.

Authors:  Z Ivics; P B Hackett; R H Plasterk; Z Izsvák
Journal:  Cell       Date:  1997-11-14       Impact factor: 41.582

8.  Transient siRNA-mediated attenuation of liver expression from an alpha-galactosidase A plasmid reduces subsequent humoral immune responses to the transgene product in mice.

Authors:  Qiuming Chu; Macy Joseph; Malgorzata Przybylska; Nelson S Yew; Ronald K Scheule
Journal:  Mol Ther       Date:  2005-08       Impact factor: 11.454

9.  Transcription start regions in the human genome are favored targets for MLV integration.

Authors:  Xiaolin Wu; Yuan Li; Bruce Crise; Shawn M Burgess
Journal:  Science       Date:  2003-06-13       Impact factor: 47.728

10.  Selection of target sites for mobile DNA integration in the human genome.

Authors:  Charles Berry; Sridhar Hannenhalli; Jeremy Leipzig; Frederic D Bushman
Journal:  PLoS Comput Biol       Date:  2006-11-24       Impact factor: 4.475

View more
  72 in total

1.  An adaptable system for improving transposon-based gene expression in vivo via transient transgene repression.

Authors:  Joseph E Doherty; Lauren E Woodard; Adham S Bear; Aaron E Foster; Matthew H Wilson
Journal:  FASEB J       Date:  2013-06-10       Impact factor: 5.191

2.  Single-cell optoporation and transfection using femtosecond laser and optical tweezers.

Authors:  Muhammad Waleed; Sun-Uk Hwang; Jung-Dae Kim; Irfan Shabbir; Sang-Mo Shin; Yong-Gu Lee
Journal:  Biomed Opt Express       Date:  2013-08-07       Impact factor: 3.732

3.  Stable transgene expression in primitive human CD34+ hematopoietic stem/progenitor cells, using the Sleeping Beauty transposon system.

Authors:  Teiko Sumiyoshi; Nathalia G Holt; Roger P Hollis; Shundi Ge; Paula M Cannon; Gay M Crooks; Donald B Kohn
Journal:  Hum Gene Ther       Date:  2009-12       Impact factor: 5.695

4.  PiggyBac transposon-based inducible gene expression in vivo after somatic cell gene transfer.

Authors:  Sai K Saridey; Li Liu; Joseph E Doherty; Aparna Kaja; Daniel L Galvan; Bradley S Fletcher; Matthew H Wilson
Journal:  Mol Ther       Date:  2009-10-06       Impact factor: 11.454

Review 5.  Efficacy and safety of Sleeping Beauty transposon-mediated gene transfer in preclinical animal studies.

Authors:  Perry B Hackett; Elena L Aronovich; David Hunter; Myra Urness; Jason B Bell; Steven J Kass; Laurence J N Cooper; Scott McIvor
Journal:  Curr Gene Ther       Date:  2011-10       Impact factor: 4.391

Review 6.  The Sleeping Beauty transposon system: a non-viral vector for gene therapy.

Authors:  Elena L Aronovich; R Scott McIvor; Perry B Hackett
Journal:  Hum Mol Genet       Date:  2011-04-01       Impact factor: 6.150

7.  A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinoma.

Authors:  Vincent W Keng; Augusto Villanueva; Derek Y Chiang; Adam J Dupuy; Barbara J Ryan; Ilze Matise; Kevin A T Silverstein; Aaron Sarver; Timothy K Starr; Keiko Akagi; Lino Tessarollo; Lara S Collier; Scott Powers; Scott W Lowe; Nancy A Jenkins; Neal G Copeland; Josep M Llovet; David A Largaespada
Journal:  Nat Biotechnol       Date:  2009-02-22       Impact factor: 54.908

Review 8.  Mouse models for liver cancer.

Authors:  Latifa Bakiri; Erwin F Wagner
Journal:  Mol Oncol       Date:  2013-02-05       Impact factor: 6.603

Review 9.  Transposon mouse models to elucidate the genetic mechanisms of hepatitis B viral induced hepatocellular carcinoma.

Authors:  Amy P Chiu; Barbara R Tschida; Lilian H Lo; Branden S Moriarity; Dewi K Rowlands; David A Largaespada; Vincent W Keng
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

10.  Quantitative real-time polymerase chain reaction (qRT-PCR) restriction fragment length polymorphism (RFLP) method for monitoring highly conserved transgene expression during gene therapy.

Authors:  Carol M Bruzzone; John D Belcher; Nathan J Schuld; Kristal A Newman; Julie Vineyard; Julia Nguyen; Chunsheng Chen; Joan D Beckman; Clifford J Steer; Gregory M Vercellotti
Journal:  Transl Res       Date:  2008-11-04       Impact factor: 7.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.